Literature DB >> 31634795

The Development of Health Technology Assessment in Asia: Current Status and Future Trends.

Gordon Liu1, Eric Q Wu2, Jeonghoon Ahn3, Isao Kamae4, Jipan Xie5, Hongbo Yang5.   

Abstract

Health technology assessment (HTA) has long been employed by many countries around the world, but its adoption in Asia has been slower. Only recently have a growing number of Asian countries started to implement HTA for pricing and reimbursement decisions. The objective of this article is to provide an overview of how HTA has been or is being implemented in Asia within the context of a country's existing-and often complex-coverage, reimbursement, and pricing schemes. Three countries at different stages of HTA implementation were selected as case studies: South Korea, where there is a young yet established HTA program; Japan, where a 3-year HTA pilot program has just concluded; and China, where HTA efforts are underway but have not been formally implemented. Not only do the experiences of these 3 countries well exemplify how the organization and scope of HTA can be customized to meet a country's unique healthcare needs, but they also provide the opportunity to outline some common key challenges that must be overcome to implement and develop HTA competencies and capabilities.
Copyright © 2019 ISPOR--The professional society for health economics and outcomes research. Published by Elsevier Inc. All rights reserved.

Keywords:  Asia; global healthcare systems; health technology assessment; value assessment

Mesh:

Year:  2019        PMID: 31634795     DOI: 10.1016/j.vhri.2019.08.472

Source DB:  PubMed          Journal:  Value Health Reg Issues        ISSN: 2212-1099


  7 in total

Review 1.  Which Criteria are Considered and How are They Evaluated in Health Technology Assessments? A Review of Methodological Guidelines Used in Western and Asian Countries.

Authors:  Yitong Wang; Tingting Qiu; Junwen Zhou; Clément Francois; Mondher Toumi
Journal:  Appl Health Econ Health Policy       Date:  2021-01-11       Impact factor: 2.561

2.  Healthcare providers' digital competency: a cross-sectional survey in a low-income country setting.

Authors:  Kirubel Biruk Shiferaw; Binyam Chakilu Tilahun; Berhanu Fikadie Endehabtu
Journal:  BMC Health Serv Res       Date:  2020-11-09       Impact factor: 2.655

3.  Informing policy makers on the efficiency of population level tobacco control interventions in Asia: A systematic review of model-based economic evaluations.

Authors:  Ariuntuya Tuvdendorj; Yihui Du; Grigory Sidorenkov; Erik Buskens; Geertruida H de Bock; Talitha Feenstra
Journal:  J Glob Health       Date:  2020-12       Impact factor: 4.413

4.  Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?

Authors:  Cong Huang; Carolina Oi Lam Ung; Haishaerjiang Wushouer; Lin Bai; Tao Huang; Xinyi Li; Xiaodong Guan; Luwen Shi
Journal:  Health Res Policy Syst       Date:  2022-01-03

5.  Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life.

Authors:  Dan Cai; Si Shi; Shan Jiang; Lei Si; Jing Wu; Yawen Jiang
Journal:  Eur J Health Econ       Date:  2021-10-16

Review 6.  Need for HTA supported risk factor screening for hypertension and diabetes in Nepal: A systematic scoping review.

Authors:  Chiranjivi Adhikari; Rojana Dhakal; Lal Mani Adhikari; Bijaya Parajuli; Khem Raj Subedi; Yeshoda Aryal; Arjun Kumar Thapa; Komal Shah
Journal:  Front Cardiovasc Med       Date:  2022-08-01

Review 7.  Evolving Treatment of Advanced Hepatocellular Carcinoma in the Asia-Pacific Region: A Review and Multidisciplinary Expert Opinion.

Authors:  Sadahisa Ogasawara; Su-Pin Choo; Jiang-Tao Li; Changhoon Yoo; Bruce Wang; Dee Lee; Pierce K H Chow
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.